Jetstream G2 NXT
Related Content
Feb. 3, 2025 — Today, Peripheral Artery Disease (PAD) affects 10 million Americans and is the most common cause of limb ...
Jan. 13, 2025 – R3 Vascular Inc., a medical device company dedicated to treating peripheral arterial disease (PAD) ...
A new study reports persistent disparities in outcomes for people with peripheral artery disease (PAD) and its more ...
Dec. 13, 2024 – Sensome has announced positive results from two studies of its Clotild Smart Guidewire System ...
Nov. 18, 2024 — In November, Esperion presented an analysis from the CLEAR Outcomes study focused on patients with ...
Nov. 4, 2024 — Royal Philips recently announced enrollment of the first patient in the U.S. THOR IDE clinical trial ...
Sept. 16, 2024 – Shockwave Medical, Inc., part of Johnson & Johnson MedTech, has announced the full U.S. launch of the ...
Sept. 1, 2024 — September is Peripheral Artery Disease (PAD) Awareness Month, a time to educate and empower people to ...
May 16, 2024 — Timely diagnosis and proper management of peripheral artery disease (PAD), including coordinated care ...
May 8, 2024 — In a groundbreaking development, a study published in the Journal of Vascular Surgery reveals for the ...